Conditioned pain modulation is not altered in recreational athletes with Achilles tendinopathy

Mkumbuzi, Nonhlanhla S.; Mafu, Trevor S.; September, Alison V.; Posthumus, Michael; Collins, Malcolm

doi:10.1002/tsm2.201

Cited by 3 publications

(4 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mkumbuzi et al confirmed that the Brief Pain Inventory is a valid tool for measuring pain intensity and impact in athletes. 37 The study included a sample of athletes from various sports and found that the BPI can be used to accurately assess and manage pain in this population. 37 …”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Longitudinal Validation of a Specific Measure of Fear Avoidance in Athletes: Predicting Time from Injury to Return to Sports Competition

Tito¹,

Porter²,

Castonguay³

et al. 2023

JPR

View full text Add to dashboard Cite

Purpose We developed the Athlete Fear Avoidance Questionnaire (AFAQ) to measure fear avoidance in athletes. Previous fear avoidance scales were developed for the general population and have demonstrated significant predictive capabilities regarding rehabilitation. No research to date has examined the association between athlete fear avoidance as measured by the AFAQ and the rehabilitation time in athletes. Patients and Methods Fifty-nine athletes who were injured during sport season participated in the study (40 males and 19 females). At injury onset, all participants completed self-report functional questionnaires. In addition, we measured multiple aspects of fear avoidance including athlete fear avoidance (AFAQ), kinesiophobia (TSK), and pain catastrophizing (PCS). Finally, we assessed pain severity and interference, as well as depression. Once the athletes were able to return to competition all participants answered the questionnaires again. Pearson correlations and a regression analysis were used to identify relationships between function, psychological variables, pain, and return to competition time. Results The AFAQ yielded the strongest correlation with return to competition time ( r =0.544, p <0.001). In addition, function at initial injury time and pain interference were also significantly correlated with return to competition time ( r =0.442, p <0.001 and r =0.356, p =0.006 respectively). Athlete fear-avoidance combined with function at the time of injury explained 34% of the variance of return to competition time in the multivariate regression model ( p <0.001). Conclusion Athlete fear-avoidance as measured by the AFAQ is associated with rehabilitation time and returning to competition in injured athletes. Psychosocial factors including athlete fear avoidance may explain why some athletes take longer to rehabilitate than others and should be evaluated in athletes who are taking longer than anticipated to complete their rehabilitation. Reducing athlete fear avoidance may facilitate rehabilitation in future studies.

show abstract

Section: Methodsmentioning

confidence: 99%

“… 37 The study included a sample of athletes from various sports and found that the BPI can be used to accurately assess and manage pain in this population. 37 …”

Section: Methodsmentioning

confidence: 99%

Longitudinal Validation of a Specific Measure of Fear Avoidance in Athletes: Predicting Time from Injury to Return to Sports Competition

Tito¹,

Porter²,

Castonguay³

et al. 2023

JPR

View full text Add to dashboard Cite

show abstract

“…Included studies were published between 1984 and 2020 (median [interquartile range (IQR)], 2014 [2008][2009][2010][2011][2012][2013][2014][2015][2016][2017][2018]), consisting of 29% (89/307) randomized trials [5,, 6% (17/307) non-randomized trials [99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115][116], 26% (81/307) single cohort [3,4,6,, 33% (101/307) case series , 3% (8/307) case-control studies [128,[288][289][290][291][292][293][294], and 4% (11/307) pilot or feasibility trials [295][296][297][298][299][300][301][302]…”

Section: Characteristics Of the Included Studiesmentioning

confidence: 99%

“…'Ankle range of motion' was reported in 4% (13/307) of the studies [17, 45, 48, 63-66, 85, 203, 242, 259, 296] and one study [259] reported first metatarsophalangeal joint range of motion. 'Pain and or tenderness with palpation' was reported in 4% (11/307) of the studies [18,37,45,48,53,77,98,113,207,234,279], and 'Sensory modality specific pain' was reported in 4% (14/307) of the studies [13,42,49,60,65,90,94,105,108,177,215,218,238,309].…”

Section: Achilles Tendinopathy Specific Domainsmentioning

confidence: 99%

ICON 2020—International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy

et al. 2021

View full text Add to dashboard Cite

Background Nine core domains for tendinopathy have been identified. For Achilles tendinopathy there is large variation in outcome measures used, and how these fit into the core domains has not been investigated. Objective To identify all available outcome measures outcome measures used to assess the clinical phenotype of Achilles tendinopathy in prospective studies and to map the outcomes measures into predefined health-related core domains. Design Systematic review. Data Sources Embase, MEDLINE (Ovid), Web of Science, CINAHL, The Cochrane Library, SPORTDiscus and Google Scholar. Eligibility Criteria for Selecting Studies Clinical diagnosis of Achilles tendinopathy, sample size ≥ ten participants, age ≥ 16 years, and the study design was a randomized or non-randomized clinical trial, observational cohort, single-arm intervention, or case series. Results 9376 studies were initially screened and 307 studies were finally included, totaling 13,248 participants. There were 233 (177 core domain) different outcome measures identified across all domains. For each core domain outcome measures were identified, with a range between 8 and 35 unique outcome measures utilized for each domain. The proportion of studies that included outcomes for predefined core domains ranged from 4% for the psychological factors domain to 72% for the disability domain. Conclusion 233 unique outcome measures for Achilles tendinopathy were identified. Most frequently, outcome measures were used within the disability domain. Outcome measures assessing psychological factors were scarcely used. The next step in developing a core outcome set for Achilles tendinopathy is to engage patients, clinicians and researchers to reach consensus on key outcomes measures. Prospero Registration CRD42020156763.

show abstract

Conditioned Pain Modulation Does Not Differ Between People With Lower-Limb Tendinopathy and Nontendinopathy Controls: A Systematic Review With Individual Participant Data Meta-analysis

Murphy,

Mkumbuzi,

Keightley

et al. 2024

Journal of Orthopaedic & Sports Physical Therapy

View full text Add to dashboard Cite

Conditioned pain modulation is not altered in recreational athletes with Achilles tendinopathy

Cited by 3 publications

References 31 publications

Longitudinal Validation of a Specific Measure of Fear Avoidance in Athletes: Predicting Time from Injury to Return to Sports Competition

Longitudinal Validation of a Specific Measure of Fear Avoidance in Athletes: Predicting Time from Injury to Return to Sports Competition

ICON 2020—International Scientific Tendinopathy Symposium Consensus: A Systematic Review of Outcome Measures Reported in Clinical Trials of Achilles Tendinopathy

Conditioned Pain Modulation Does Not Differ Between People With Lower-Limb Tendinopathy and Nontendinopathy Controls: A Systematic Review With Individual Participant Data Meta-analysis

Contact Info

Product

Resources

About